{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:38:18Z","timestamp":1781566698052,"version":"3.54.5"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Retinoid-induced myositis is a phenomenon recognised in multiple case reports. We report a case of isotretinoin-induced myositis in an 18-year-old male patient. This case adds to the published literature as it demonstrates (i) myositis may occur after extended periods of isotretinoin use, (ii) should be considered as a differential diagnosis even when presenting asymmetrically and (iii) can continue to progress clinically and biochemically initially following the suspension of isotretinoin before being effectively treated with corticosteroids.<\/jats:p>","DOI":"10.1093\/omcr\/omae017","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T12:56:22Z","timestamp":1711371382000},"source":"Crossref","is-referenced-by-count":2,"title":["Isotretinoin-induced myositis"],"prefix":"10.1093","volume":"2024","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2644-9191","authenticated-orcid":false,"given":"Oliver","family":"Hague","sequence":"first","affiliation":[{"name":"Royal Free Hospital Department of Rheumatology, , London NW3 2QG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Thanopoulou","sequence":"additional","affiliation":[{"name":"Royal Free Hospital Department of Rheumatology, , London NW3 2QG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Mangat","sequence":"additional","affiliation":[{"name":"Royal Free Hospital Department of Rheumatology, , London NW3 2QG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Animesh","family":"Singh","sequence":"additional","affiliation":[{"name":"Royal Free Hospital Department of Rheumatology, , London NW3 2QG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Stratton","sequence":"additional","affiliation":[{"name":"Royal Free Hospital Department of Rheumatology, , London NW3 2QG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamir","family":"Malley","sequence":"additional","affiliation":[{"name":"Royal Free Hospital Department of Rheumatology, , London NW3 2QG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"2024032512561207300_ref1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2340\/00015555-2535","article-title":"Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity","volume":"97","author":"Melnik","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"2024032512561207300_ref2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.46497\/ArchRheumatol.2022.8645","article-title":"Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: a cross-sectional study","volume":"37","author":"Acar","year":"2022","journal-title":"Arch Rheumatol"},{"key":"2024032512561207300_ref3","doi-asserted-by":"crossref","first-page":"e917801","DOI":"10.12659\/AJCR.917801","article-title":"Myositis induced by isotretinoin: a case report and literature review","volume":"21","author":"Rivillas","year":"2020","journal-title":"Am J Case Rep"},{"key":"2024032512561207300_ref4","doi-asserted-by":"crossref","first-page":"e12483","DOI":"10.1111\/dth.12483","article-title":"Adverse effects of isotretinoin: a large, retrospective review","volume":"30","author":"Brzezinski","year":"2017","journal-title":"Dermatol Ther"},{"key":"2024032512561207300_ref5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ijd.14758","article-title":"The creatine kinase conundrum: a reappraisal of the association of isotretinoin, creatine kinase, and rhabdomyolysis","volume":"59","author":"Marson","year":"2020","journal-title":"Int J Dermatol"},{"key":"2024032512561207300_ref6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.5414\/CP201874","article-title":"The effect of genetic polymorphisms of RARA gene on the adverse effects profile of isotretinoin-treated acne patients","volume":"51","author":"Alzoubi","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2024032512561207300_ref7","doi-asserted-by":"crossref","first-page":"101765","DOI":"10.1016\/j.berh.2022.101765","article-title":"Muscle imaging in myositis: MRI, US, and PET","volume":"36","author":"Albayda","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2024032512561207300_ref8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pmr.2012.08.017","article-title":"Electrodiagnostic evaluation of myopathies","volume":"24","author":"Paganoni","year":"2013","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"2024032512561207300_ref9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11940-022-00718-3","article-title":"Toxic myopathies","volume":"24","author":"Mclntosh","year":"2022","journal-title":"Curr Treat Options Neurol"}],"container-title":["Oxford Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2024\/3\/omae017\/57076312\/omae017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2024\/3\/omae017\/57076312\/omae017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T12:56:28Z","timestamp":1711371388000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/omcr\/article\/doi\/10.1093\/omcr\/omae017\/7634389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/omcr\/omae017","relation":{},"ISSN":["2053-8855"],"issn-type":[{"value":"2053-8855","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2024,3,1]]},"article-number":"omae017"}}